Celcuity CELC
NASDAQ CELC
$65.57 +4.01 (+6.51%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025)

Updated

Analysis

Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Celcuity 3.21 Bn 2.45 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.27 Mn
Sep 30, 2025 778,000.00
Jun 30, 2025 537,000.00
Mar 31, 2025 551,000.00
Dec 31, 2024 551,000.00
Sep 30, 2024 478,000.00
Jun 30, 2024 237,000.00
Mar 31, 2024 65,000.00
Dec 31, 2023 63,813.00
Sep 30, 2023 61,721.00
Jun 30, 2023 59,214.00
Mar 31, 2023 57,004.00
Dec 31, 2022 111,573.00
Sep 30, 2022 104,645.00
Jun 30, 2022 84,527.00
Mar 31, 2022 95,012.00
Dec 31, 2021 94,460.00
Sep 30, 2021 91,790.00
API Access

Celcuity Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CELC&period=max&api_key=YOUR_API_KEY